Hypericum beanii N. Robson, a perennial upright herb, predominantly inhabits temperate regions. This species has been utilized for the treatment of various inflammation-related diseases. One new xanthone 3,7-dihydroxy-1,6-dimethoxyxanthone (
1) and twenty-three known xanthones (
2–
24) were isolated from
[...] Read more.
Hypericum beanii N. Robson, a perennial upright herb, predominantly inhabits temperate regions. This species has been utilized for the treatment of various inflammation-related diseases. One new xanthone 3,7-dihydroxy-1,6-dimethoxyxanthone (
1) and twenty-three known xanthones (
2–
24) were isolated from the aerial parts of
H. beanii. The structure of the new compound was determined based on high-resolution electrospray ionization mass spectroscopy (HR-ESIMS), nuclear magnetic resonance (NMR), Infrared Spectroscopy (IR), ultraviolet spectrophotometry (UV) spectroscopic data. The anti-inflammatory effects of all the isolates were assessed by measuring the inhibitory effect on nitric oxide (NO) production in LPS-stimulated RAW 264.7 macrophages. Compounds 3,4-dihydroxy-2-methoxyxanthone (
15), 1,3,5,6-tetrahydroxyxanthone (
19), and 1,3,6,7-tetrahydroxyxanthone (
22) exhibited significant anti-inflammatory effects at a concentration of 10
μM with higher potency compared to the positive control quercetin. Furthermore, compounds
15,
19, and
22 reduced inducible NO synthase (iNOS), tumor necrosis factor alpha (TNF-
α), interleukin-1
β (IL-1
β), IL-6, and cyclooxygenase 2 (COX-2) mRNA expression in the LPS-stimulated RAW 264.7 macrophages, suggesting that these compounds may mitigate the synthesis of the aforementioned molecules at the transcriptional level, provisionally confirming their anti-inflammatory efficacy.
Full article